Dcf Advisers, LLC Prothena Corp Public LTD CO Transaction History

Dcf Advisers, LLC

$242 Million
Q3 2024

A detailed history of Dcf Advisers, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Dcf Advisers, LLC holds 107,500 shares of PRTA stock, worth $1.62 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

107,500

Previous 107,500 -0.0%

Holding current value

$1.62 Million

Previous $2.22 Million 18.94%

% of portfolio

0.74%

Previous 1.2%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$19.54 - $26.15 $9,770 - $13,075	500 Added 0.47%	107,500 $2.22 Million
Q1 2024 May 15, 2024	BUY	$24.75 - $40.66 $569,250 - $935,179	23,000 Added 27.38%	107,000 $2.65 Million
Q4 2023 Feb 13, 2024	BUY	$32.31 - $52.32 $33,925 - $54,936	1,050 Added 1.27%	84,000 $3.05 Million
Q3 2023 Nov 13, 2023	SELL	$47.3 - $70.6 $85,140 - $127,079	-1,800 Reduced 2.12%	82,950 $4 Million
Q2 2023 Aug 09, 2023	BUY	$48.26 - $78.59 $24,130 - $39,295	500 Added 0.59%	84,750 $5.79 Million
Q1 2023 May 15, 2023	BUY	$46.97 - $58.27 $476,745 - $591,440	10,150 Added 13.7%	84,250 $4.08 Million
Q4 2022 Feb 13, 2023	BUY	$52.05 - $65.0 $317,505 - $396,500	6,100 Added 8.97%	74,100 $4.46 Million
Q3 2022 Nov 14, 2022	BUY	$25.16 - $60.63 $3,623 - $8,730	144 Added 0.21%	68,000 $4.12 Million
Q2 2022 Aug 11, 2022	SELL	$22.73 - $39.98 $185,113 - $325,597	-8,144 Reduced 10.72%	67,856 $1.84 Million
Q1 2022 May 13, 2022	BUY	$30.27 - $49.22 $484,320 - $787,520	16,000 Added 26.67%	76,000 $2.78 Million
Q3 2021 Nov 15, 2021	SELL	$48.2 - $78.89 $84,350 - $138,057	-1,750 Reduced 2.83%	60,000 $4.27 Million
Q2 2021 Aug 13, 2021	BUY	$21.63 - $57.65 $343,787 - $916,289	15,894 Added 34.66%	61,750 $3.18 Million
Q1 2021 May 12, 2021	BUY	$11.0 - $28.24 $504,416 - $1.29 Million	45,856 New	45,856 $1.15 Million

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $708M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dcf Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dcf Advisers, LLC with notifications on news.

Account